$2.04 Billion is the total value of NEA Management Company, LLC's 28 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 24.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GRPN | GROUPON INC | $426,116,000 | -33.4% | 54,351,582 | 0.0% | 20.92% | -32.3% | |
TSRO | Sell | TESARO INC | $290,503,000 | +4.3% | 9,854,255 | -0.1% | 14.26% | +6.0% |
CVT | Sell | CVENT INC | $216,763,000 | -18.4% | 5,996,212 | -17.9% | 10.64% | -17.1% |
CLVS | CLOVIS ONCOLOGY INC | $157,920,000 | +14.9% | 2,279,781 | 0.0% | 7.75% | +16.8% | |
EPZM | EPIZYME INC | $146,777,000 | +9.5% | 6,446,089 | 0.0% | 7.21% | +11.2% | |
GLYC | New | GLYCOMIMETICS INC | $140,032,000 | – | 8,575,135 | +100.0% | 6.88% | – |
SUPN | SUPERNUS PHARMACEUTICALS INC | $95,211,000 | +18.6% | 10,650,000 | 0.0% | 4.67% | +20.5% | |
HPTX | HYPERION THERAPEUTICS INC | $74,413,000 | +27.6% | 2,884,221 | 0.0% | 3.65% | +29.6% | |
FIO | FUSION-IO INC | $74,044,000 | +18.1% | 7,038,379 | 0.0% | 3.64% | +20.0% | |
MM | MILLENNIAL MEDIA INC | $56,915,000 | -4.8% | 8,224,752 | 0.0% | 2.79% | -3.3% | |
ITMN | INTERMUNE INC | $44,883,000 | +127.2% | 1,341,000 | 0.0% | 2.20% | +130.9% | |
SNSS | SUNESIS PHARMACEUTICALS INC | $37,258,000 | +39.5% | 5,636,573 | 0.0% | 1.83% | +41.7% | |
RNA | New | PROSENSA HLDG N V | $36,483,000 | – | 6,480,171 | +100.0% | 1.79% | – |
WIFI | BOINGO WIRELESS INC | $30,293,000 | +5.8% | 4,467,960 | 0.0% | 1.49% | +7.4% | |
TRVN | New | TREVENA INC | $29,960,000 | – | 3,811,691 | +100.0% | 1.47% | – |
NKTR | NEKTAR THERAPEUTICS | $22,126,000 | +6.8% | 1,825,600 | 0.0% | 1.09% | +8.5% | |
TRGT | TARGACEPT INC | $21,692,000 | +14.5% | 4,566,666 | 0.0% | 1.06% | +16.3% | |
ECOM | Sell | CHANNELADVISOR CORP | $21,010,000 | -69.7% | 556,692 | -66.5% | 1.03% | -69.2% |
LXRX | LEXICON PHARMACEUTICALS INC | $20,199,000 | -3.9% | 11,676,000 | 0.0% | 0.99% | -2.3% | |
ZHNE | ZHONE TECHNOLOGIES INC | $20,177,000 | -21.0% | 4,781,290 | 0.0% | 0.99% | -19.7% | |
Sell | ALIMERA SCIENCES INC | $17,797,000 | +41.2% | 2,255,639 | -15.9% | 0.87% | +43.5% | |
RIGL | RIGEL PHARMACEUTICALS INC | $12,583,000 | +36.1% | 3,243,150 | 0.0% | 0.62% | +38.3% | |
OREX | OREXIGEN THERAPEUTICS INC | $12,579,000 | +15.4% | 1,935,300 | 0.0% | 0.62% | +17.5% | |
FOLD | AMICUS THERAPEUTICS INC | $11,702,000 | -11.9% | 5,653,029 | 0.0% | 0.57% | -10.6% | |
EXEL | EXELIXIS INC | $7,813,000 | -42.2% | 2,207,000 | 0.0% | 0.38% | -41.3% | |
TSPT | TRANSCEPT PHARMACEUTICALS INC | $6,427,000 | -8.3% | 2,086,755 | 0.0% | 0.32% | -6.8% | |
ARQL | ARQULE INC | $5,167,000 | -4.7% | 2,520,316 | 0.0% | 0.25% | -3.1% | |
NURO | NEUROMETRIX INC | $134,000 | -19.8% | 57,273 | 0.0% | 0.01% | -12.5% | |
WDAY | Exit | WORKDAY INCcl a | $0 | – | -4,930 | -100.0% | -0.02% | – |
SLTM | Exit | SOLTA MED INC | $0 | – | -2,859,577 | -100.0% | -0.41% | – |
CADX | Exit | CADENCE PHARMACEUTICALS INC | $0 | – | -2,070,286 | -100.0% | -0.90% | – |
GLUU | Exit | GLU MOBILE INC | $0 | – | -5,943,793 | -100.0% | -1.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-01
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
TREVENA INC | 31 | Q3 2021 | 3.3% |
AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
ARDELYX INC | 29 | Q3 2021 | 11.9% |
RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.